<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: cardinal health</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cardinal health'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22cardinal+health%22&t=%22cardinal+health%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:50:14 +0100</lastBuildDate>
        <item>
            <title>The Continuing Parade of Legal Settlements by Health Care Organizations: Cardinal, Cerberus, Dartmouth-Hitchcock, Masonicare</title>
            <link>http://www.medworm.com/index.php?rid=4775352&amp;cid=t_142097_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2011%2F05%2Fcontinuing-parade-of-legal-settlements.html</link>
            <description>Here is our latest round-up of the more colorful legal settlements made by some US health care organizations.Cardinal HealthCardinal Health is a pharmaceutical services company. Per the Kansas City Star:A pharmaceutical distributor has settled a federal anti-kickback lawsuit by agreeing, in part, to pay $760,000 to former Kansas City Chiefs player Dan Saleaumua and a consultant.That money is part of an $8 million settlement that Cardinal Health Inc. of Ohio agreed to pay the U.S. government to settle the lawsuit.The lawsuit alleged that Cardinal offered Saleaumua and consultant Kevin Rinne an illegal $440,000 kickback so it could supply prescription drugs to seven Kansas City area Medicine Shoppe pharmacies that Saleaumua owned at the time.Cerberus Capital Management/ Dyncorp/ Steward Heal...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4775352</comments>
            <pubDate>Mon, 02 May 2011 19:00:00 +0100</pubDate>
            <guid isPermaLink="false">4775352</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4753973&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F6I6iFNkZiNw%2F</link>
            <description>Hello, everyone. Another shiny day is unfolding on the Pharmalot corporate campus, where we have successfully begun hustling the short people off to the local school house. As for us, we have a busy day planned since we will host a webinar later about pharma ad agencies and procurement issues (look here). Meanwhile, here are some tidbits to get you started. Hope today is a productive one and see you soon&amp;#8230;
Merck Hep C Drug Boosted Cure Rates In Trials: FDA (Bloomberg News)
Abbott Trilipix &amp;#038; Statin Combo Can Cause Heart Problems: FDA (Reuters)
Painkillers Make Antidepressants Less Effective: Study (The Globe &amp;#038; Mail)
Cardinal Health Pays $8M To Settle Kickback Claims (Kansas City Business Journal)
Mitsui Buys CMO Operations In China (Outsourcing Pharma) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4753973</comments>
            <pubDate>Tue, 26 Apr 2011 12:03:01 +0100</pubDate>
            <guid isPermaLink="false">4753973</guid>        </item>
        <item>
            <title>Cardinal Health Settles, Novartis Settles</title>
            <link>http://www.medworm.com/index.php?rid=3298273&amp;cid=t_142097_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2010%2F02%2Fcardinal-health-settles-novartis.html</link>
            <description>And the march of settlements continues....As reported by the Tulsa (Oklahoma) World,A company that provides hospital pharmacy management services in Tulsa has agreed to pay $1 million in civil penalties for failing to account for large amounts of missing prescription drugs, the U.S. Attorney's Office in Tulsa announced Friday.Cardinal Health Pharmacy Services agreed to settle allegations with the federal prosecutors' office, which alleged that the company's two Tulsa pharmacies were negligent and violated several provisions of the Controlled Substances Act.An audit showed that nearly 400,000 dosage units of hydrocodone, a painkiller, and 234,000 units of alprazolam, an anti-anxiety drug, were unaccounted for at the Hillcrest Medical Center pharmacy from October 2005 through June 2007, acco...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3298273</comments>
            <pubDate>Mon, 22 Feb 2010 22:09:00 +0100</pubDate>
            <guid isPermaLink="false">3298273</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3294809&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FPxiU-CUwnfE%2F</link>
            <description>Hello, everyone, and welcome back from the weekend. We hope your time was relaxing and you had a chance to enjoy. Now, the routine, of course, returns. What lies in store this week? We can only guess, but to prepare, we are brewing the required cup of stimulation. Grab one yourself. Meanwhile, here are a few items to help you get moving. Good luck&amp;#8230;
Icahn Wants Four Genzyme Board Seats (TheStreet)
USPTO Tentatively Rejects Plavix Patent (Dow Jones)
Cardinal Pays $1M Fine For Missing Drugs (Columbus Business First)
Novartis Wins FDA OK For Meningitis Vaccine (MarketWatch)
Anthera Tries IPO With No Sales Or Products (Bloomberg News)
FDA To Decide On Amgen Prolia By July (Reuters)
EU Rejects J&amp;#038;J Drug For Skin Infections (Associated Press)
Hologic Settles Patent Suit With J&amp;#038;J (R...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3294809</comments>
            <pubDate>Mon, 22 Feb 2010 12:41:25 +0100</pubDate>
            <guid isPermaLink="false">3294809</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=3056882&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FJB_ObJOoTjc%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
Jazz Pharmaceuticals hired Kathryn Falberg as senior vp and cfo;
NovaDigm Therapeutics named R. Gordon Douglas as chairman;
Pfizer named Adele Gulfo as US president of its primary care business;
Amarin hired Joe Zakrzewski as executive chairman;
Cardinal Health added Carrie Cox to its board of directors;
Catalent Pharma Solutions hired Paul Burns as vp of global sales;
Kfor...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3056882</comments>
            <pubDate>Fri, 04 Dec 2009 13:24:18 +0100</pubDate>
            <guid isPermaLink="false">3056882</guid>        </item>
        <item>
            <title>Cardinal Pays $34M For Violating Substances Act</title>
            <link>http://www.medworm.com/index.php?rid=1852739&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F410350224%2F</link>
            <description>The big distributor was charged with failing to report suspicious sales of hydrocodone, which is a violation under the Controlled Substances Act, despite repeated warnings, according to the US Drug Enforcement Agency. The med was later distributed to pharmacies that filled illegitimate prescriptions from rogue Internet pharmacies.
Drugmakers and distributors are required to monitor and report suspicious orders of controlled substances. But the DEA says Cardinal allowed the diversion of millions of dosage units of hydrocodone, which is the generic name of a prescription painkiller that is classified under federal narcotics law as a Schedule III controlled substance.
Cardinal&amp;#8217;s &amp;#8220;negligent conduct contributed to our nation&amp;#8217;s serious pharmaceutical abuse problem,&amp;#8221; Miche...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1852739</comments>
            <pubDate>Fri, 03 Oct 2008 15:12:17 +0100</pubDate>
            <guid isPermaLink="false">1852739</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… What Economy?</title>
            <link>http://www.medworm.com/index.php?rid=1841250&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F406527891%2F</link>
            <description>The stock market plunge reminds Pharmalot of the following true story: As Chicken Little walks down Wall Street, he’s heard shouting ‘The Sky Is Falling!’ Right on cue, a wiseguy broker from Brooklyn opens his window and shouts, &amp;#8216;Sell Sky!&amp;#8217; &amp;#8230;Hang on, everyone. And try not to panic.
Covance Abandons Plan For Research Venture In China (NJ.com)
Cardinal Health To Spin Off Medical Products Unit (Yahoo/Reuters)
Will Lending Woes Hurt Roche Bid For Genentech? (The Financial Times) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1841250</comments>
            <pubDate>Mon, 29 Sep 2008 19:22:44 +0100</pubDate>
            <guid isPermaLink="false">1841250</guid>        </item>
        <item>
            <title>Cardinal Fined For Shipping To Rogue Pharmacy</title>
            <link>http://www.medworm.com/index.php?rid=1631583&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F337125000%2F</link>
            <description>The big wholesaler has agreed to pay a fine of $105,000 to settle a charge by the Ohio State Board of Pharmacy that it failed to report increases in drug orders from a rogue pharmacist, The Columbus Dispatch reports. 
The fine relates to Cardinal Health&amp;#8217;s shipments of controlled substances to Caringwell Pharmacy in Dublin, Ohio, from November 2006 until March 2007. The board said Cardinal provided addictive drugs, including prescription painkillers and anxiety meds, the paper writes. 
The pharmacy board, which regulates drug sellers and distributors that do business in Ohio, closed Caringwell last year for illegally selling the meds over the Internet. The board investigated Cardinal for failing to report the pharmacy had significantly increased orders of controlled substances, as is ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631583</comments>
            <pubDate>Wed, 16 Jul 2008 14:38:23 +0100</pubDate>
            <guid isPermaLink="false">1631583</guid>        </item>
        <item>
            <title>HAIs &amp; Free Lunches in Healthcare - Cardinal Health's Chasing Zero Summit</title>
            <link>http://www.medworm.com/index.php?rid=1455483&amp;cid=t_142097_118_f&amp;fid=36984&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FHealthManagementRx%2F%7E3%2F283243854%2Fhais-free-lunches-in-healthcare.html</link>
            <description>Something I received in the mail yesterday revived a bit of hope that the US hospital industry may be - FINALLY - 'getting it.'Hiding amidst all the grocery sales circulars was a flyer from Cardinal Health about the Chasing Zero Summit (Washington DC, Sept. 8-10, 2008).Those of you who are following me on Twitter.com know I've been jetting around to quite a few conferences this spring. As I try to calculate ROI for these trips more effectively, I'm being increasingly selective about the shows I think will be productive.At first I was excited about Chasing Zero - it's in my old hometown of DC, so I can see friends, family and colleagues while I'm in the area.According to the invite: &quot;The Chasing Zero Summit is designed to stimulate discussion between the industry's key stakeholders - hospit...</description>
            <author>Health Management Rx</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455483</comments>
            <pubDate>Sun, 04 May 2008 09:57:00 +0100</pubDate>
            <guid isPermaLink="false">1455483</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=1303459&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F251329033%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs being announced each month. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
Elusys Therapeutics named Robert Gundel vp of research;
Endo Pharmaceuticals hired David Holveck as ceo and president;
Mylan named Dick Markham non-executive chairman of the board;
Ovation named Chris Silber vp, clinical affairs;
Mylan&amp;#8217;s Matrix Labs named Jagdish Viswanath Dore as ceo and managing director;
Cardinal Health named Michael Kauf...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1303459</comments>
            <pubDate>Fri, 14 Mar 2008 11:04:03 +0100</pubDate>
            <guid isPermaLink="false">1303459</guid>        </item>
        <item>
            <title>Teva North America CEO Leaves For Cardinal</title>
            <link>http://www.medworm.com/index.php?rid=1142704&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F214520491%2F</link>
            <description>This seems to have caught Wall Street by surprsie. George Barrett was liked by investors and his departure is causing some analysts to wonder aloud whether the changover will be an issue. Barrett will be replaced by Bill Marth, who is currently ceo and president of Teva USA.
Barrett, meanwhile, is joining Cardinal Health, one of the big US drug wholsalers, as vice chairman and will also serve as ceo of Cardinal&amp;#8217;s health-care supply chain services sector, according to a statement. Barrett, 53, will remain with Teva through January to assist in the transition and Marth, 53, will assume the additional role of CEO of Teva North America immediately, Teva said in its own statement.
Teva stock fell more than 4 percent earlier on the news, while Cardinal shares were up.
 (more&amp;#8230;)
Share ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1142704</comments>
            <pubDate>Thu, 10 Jan 2008 17:41:44 +0100</pubDate>
            <guid isPermaLink="false">1142704</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… A News Round-Up</title>
            <link>http://www.medworm.com/index.php?rid=1079862&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F196740544%2F</link>
            <description>Before you head off to that next meeting, lunch appointment or coffee break, now may be a good time to catch up on events. Here are some of the latest&amp;#8230;.
The Drug Enforcement Administration has suspended Cardinal Health&amp;#8217;s license to distribute controlled substances from its Lakeland, Florida, distribution center, the second such suspension in about a week. In both cases - the other occurred in its Auburn, Washington, facility - the DEA says Cardinal failed to maintain effective controls in distributing to retail pharmacies, Reuters writes. The DEA cited the sale of hydrocodone to pharmacies that allegedly dispensed excessive amounts of the pain treatment, based on improper prescriptions from Internet pharmacy Web sites.
Merck will spend as much as $600 million developing medicin...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1079862</comments>
            <pubDate>Fri, 07 Dec 2007 17:20:33 +0100</pubDate>
            <guid isPermaLink="false">1079862</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Is Here</title>
            <link>http://www.medworm.com/index.php?rid=1063010&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F193247012%2F</link>
            <description>And so we turn our attention to other matters, such as raking leaves and spending time with our short people. We may even read a book. And you? Whatever your passion, we hope you enjoy the time. Meanwhile, here are a few items to help you stay abreast, even as other activities beckon&amp;#8230;
Amgen&amp;#8217;s Aranesp Data Disappoints (TheStreet.com)
Fosamax Users Seek Class-Action Lawsuit Status (Yahoo/AP)
King Pharma Options Up On Takeover Speculation (Yahoo/Reuters)
DEA Move May Not Hurt Cardinal Health (Yahoo/AP)
UK&amp;#8217;s NHS Calls For Redirecting Cancer Med Expenditures (BBC)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1063010</comments>
            <pubDate>Sat, 01 Dec 2007 01:16:58 +0100</pubDate>
            <guid isPermaLink="false">1063010</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Take A Break</title>
            <link>http://www.medworm.com/index.php?rid=1005356&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F180186631%2F</link>
            <description>A busy, busy day today. But is anyone surprised? Not us. And so as we continue to pursue various lines of inquiry, we thought we would pause to pass along a few interesting items&amp;#8230;
Lilly And Daiichi Plan New Prasugrel Study (Yahoo/Reuters)
Cardinal Health Drug Distribution Unit Is Reeling (Bloomberg News)
WHO Tries To Balance Helping The Poor And Drugmakers (Associated Press)
Cytogen Hires Advisers To Explore Options (Yahoo/Reuters)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1005356</comments>
            <pubDate>Mon, 05 Nov 2007 20:49:50 +0100</pubDate>
            <guid isPermaLink="false">1005356</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=904631&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F161496556%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Here are some of the latest moves…
Lilly names Lauren Marangell as a Distinguished Scholar;
Cardinal Health named ceo R. Kerry Clark as chairman;
Shire appointed Sylvie Gregoire as prez, human genetic therapies biz;
Cell Therapeutics adds Richard Love to its board;
MacroGenics named Jeff Buchalter as chairman;
Stiefel Labs appointed Lodewijk de Vink, to its board;
Keryx Biopharmaceuticals named Mike Tarnok to its board;
Gen-Probe named John Martin to its board;
CG Therapeutics appointed Chris Henney ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=904631</comments>
            <pubDate>Wed, 26 Sep 2007 11:29:25 +0100</pubDate>
            <guid isPermaLink="false">904631</guid>        </item>
        <item>
            <title>Up And Down The Ladder: Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=817762&amp;cid=t_142097_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F147329219%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don&amp;#8217;t be shy. Everyone wants to know who is coming and going. Here are some of the latest moves…
Cardinal Health named Vivek Jain exec vp of strategy and corporate development;
XTENT adds Mike Eagle, former Lilly manufacturing vp to its board;
Quintiles Transnational named Mike Troullis as cfo;
BioVex appointed Thaddeus Pullano vp of quality assurance;
Mediware Info Systems hired Noel Strong as chief tech officer and R&amp;#038;D vp;
AEterna Zentaris appointed Paul Blake sr vp and chief medical officer;
SpectraScience appointed Michel Vaudry as director of inte...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=817762</comments>
            <pubDate>Thu, 23 Aug 2007 11:44:54 +0100</pubDate>
            <guid isPermaLink="false">817762</guid>        </item>
    </channel>
</rss>

